1
Medtech
  • Home
  • Insights
  • APAC ▾
    • Medical Device Manufacturing
    • MedTech
    • Orthopedic
  • Europe ▾
    • In Vitro Diagnostics
    • Medical Device Manufacturing
    • Medical Imaging
    • Medtech
    • Orthopedic
  • Conferences
  • Newsletter
  • Subscribe
  • News
  • Whitepaper
  • About Us
  • Biomechanics
  • Haematology
  • Neurology
  • Orthopedic
  • Drug Delivery Device
  • Manufacturing
  • MedTech
  • Oncology
  • Urology
  • Veterinary
  • Respiratory Devices
  • MedTech Devices Startups
  • Startups
  • Gynaecology
  • Nephrology
  • Medical Device
  • Physiotherapy
  • Dental
  • Surgical
  • Simulation
  • Pediatrics
  • Imaging
  • Chronic Care
  • Nanomedicine
  • Dermatology
  • Endoscopy
  • Ophthalmics
  • Ultrasound
  • Robotics
  • Wound Care
  • Diabetes Care
  • CardioVascular
  • Packaging and Sterilization
  • In Vitro Diagnostics
  • Biomechanics
  • Haematology
  • Neurology
  • Orthopedic
  • Drug Delivery Device
  • Manufacturing
  • MedTech
  •   MORE
      • Oncology
      • Urology
      • Veterinary
      • Respiratory Devices
      • MedTech Devices Startups
      • Startups
      • Gynaecology
      • Nephrology
      • Medical Device
      • Physiotherapy
      • Dental
      • Surgical
      • Simulation
      • Pediatrics
      • Imaging
      • Chronic Care
      • Nanomedicine
      • Dermatology
      • Endoscopy
      • Ophthalmics
      • Ultrasound
      • Robotics
      • Wound Care
      • Diabetes Care
      • CardioVascular
      • Packaging/Sterilization
      • In Vitro Diagnostics
×
#

Medical Tech Outlook Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook

Subscribe

loading

THANK YOU FOR SUBSCRIBING

Editor's Pick(1 - 4 of 8)
left
Formula Five for Biotech IT

Jeffrey Keisling, CIO & SVP, Pfizer [NYSE:PFE]

Movement Analysis Offers Quantification of the Benefit of Orthopaedic Interventions

Erin M. Mannen, Ph.D., Assistant Professor of Orthopaedic Surgery and Director of Translational Orthopaedic Research at the University of Arkansas for Medical Sciences

Emerging Technologies for Offloading of the Diabetic Foot

Brian Lepow, DPM, Assistant Professor of Surgery, Baylor College of Medicine

The Coming Era of High Performance Medicine

Jason Burke, System VP, Enterprise Analytics & Data Sciences, UNC Health Care

The Biotech IT PMO 2.0

Paul Ritchie, Knowledge Strategy Leader, MassMutual

Recent Trend and Development in Pharmaceutical Industry

Richard Hu, Associate Director CMC, Curis

Rendering the Power of Integrated Biotechnology Services

Tim Jackson, VP Technology, Advanced Clinical

Advanced Technology Enables those with Physical Limitations

Jesse Rettele, Faculty, Clinical Instructor, Medical Director, L/CPO, UT Health San Antonio

right

Digitizing Pharmaceuticals

By Ashok Upadhyay, IT Sr. Director, Otsuka Pharmaceutical Development & Commercialization, Inc. (U.S.)

Tweet

Ashok Upadhyay, IT Sr. Director, Otsuka Pharmaceutical Development & Commercialization, Inc. (U.S.)Ashok Upadhyay, IT Sr. Director, Otsuka Pharmaceutical Development & Commercialization, Inc. (U.S.)

In the world of omnipresent social media and smart user-centric devices, digital technologies continue to redefine newer and better ways for people to interact with one another. Ironically the compliance-led pharma and life sciences industries have not always reacted to adapt and adopt opportunities presented by the creative and inventive union of the digital technologies (social media, mobility, big data, advanced analytics, cloud computing, and IOTs). Amidst the fierce competition in the race to discover, develop, and market novel therapies that unequivocally demonstrate improved patient outcomes, pharma and biotech CIOs must make it a priority for their enterprise IT strategies to focus on digital accelerations as one of the many ways to drive rapid business growth.

The uptake of cloud computing and cloud-based solutions across all pharmaceutical domains has opened up a multitude of possibilities. A few examples include rapid extraction of real-time multi-center clinical study data for scientific and operational analytics, population health management, heath economics and outcomes research, directly engaging with patients through the emergence of social platforms, accelerated use of digital channels for enhanced stakeholder engagement, end-to-end product tracking and real-time monitoring of consumption patterns for enriched inventory management—all of these with unmatched scalability, reliability, and data security at a fraction of the cost compared to traditional non-cloud based solutions.

"The uptake of cloud computing and cloud-based solutions across all pharmaceutical domains has opened up a multitude of possibilities"

In late 2015, U.S. FDA accepted the first digital medicine NDA for a potential product that combines an approved medicine for treating certain mental illnesses with an ingestible sensor in a single tablet to digitally record ingestion and, with patient consent, share information with their healthcare professionals and caregivers— which brings significant opportunity to demonstrate the potential of digital medicines to provide an objective measure of medication adherence and physiologic response. This is truly one of the examples of how smart devices in combination with therapeutics may have the potential to impact healthcare. Medication adherence continues to be a huge problem in an era when smart technologies may provide a solution. If I had to bet on the next wave of transformational digital therapeutics, the type of devices with the ability to connect and talk to each other without needing any cloud or server to exchange information among each other (often referred to as “Internet of Things” or IoT) would win my vote.

Both life sciences and healthcare companies have a big opportunity to change the delivery of health and wellness services through the intelligent use of such devices. Imagine a world of possibilities where a number of such sensors and devices interact with each other in a cluster of cohorts generating signals and actions to influence and create human or machine interventions across the healthcare ecosystem. The Big Data strategies are then bound to become the core competitive differentiators for pharma and biotech companies in managing such data explosion to help data scientists ask the right questions. In the process of doing so they will need to revisit the entire IT enterprise—not just by re-evaluating their current platform investment and technical approaches, but more broadly continuing to evolve their policies, organization structures, governance models and most importantly how they engage with internal and external stakeholders, researchers, patients, and customers. They will also need to develop new data strategies that reflect the shift in how data is shared and analyzed, as well as a plan to manage all types of data that affect product sales, pricing, reimbursement and other measures—all while simultaneously focusing more time, energy and investment in digitizing assets to greatly impact the ultimate outcome— disease prevention and improvement of health and wellness around the world.

tag

Big Data

inventory

IoT

Pharmaceutical

Read Also

The Biotech IT PMO 2.0

The Biotech IT PMO 2.0

Paul Ritchie, Knowledge Strategy Leader, MassMutual
Recent Trend and Development in Pharmaceutical Industry

Recent Trend and Development in Pharmaceutical Industry

Richard Hu, Associate Director CMC, Curis
Rendering the Power of Integrated Biotechnology Services

Rendering the Power of Integrated Biotechnology Services

Tim Jackson, VP Technology, Advanced Clinical
Advanced Technology Enables those with Physical Limitations

Advanced Technology Enables those with Physical Limitations

Jesse Rettele, Faculty, Clinical Instructor, Medical Director, L/CPO, UT Health San Antonio

Weekly Brief

loading
Top 10 Biomechanics Solution Companies - 2019
ON THE DECK

Biomechanics 2019

Top Vendors

Biomechanics 2018

Top Vendors

Previous Next

Featured Vendors

  • PT Genie: Transforming the Realm of Physical Therapy
    PT Genie: Transforming the Realm of Physical Therapy
  • Ermi: Non-Operative Treatment for Severe Motion Loss
    Ermi: Non-Operative Treatment for Severe Motion Loss
  • Intellirod Spine: Sensing Systems for Spine Surgeons and their Patients
    Intellirod Spine: Sensing Systems for Spine Surgeons and their Patients
  • FX Shoulder USA: The Shoulder Arthroplasty Specialist
    FX Shoulder USA: The Shoulder Arthroplasty Specialist
Copyright © 2019 Medical Tech Outlook. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Use and Privacy Policy.
follow on linkedin follow on twitter
This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

biomechanics.medicaltechoutlook.com/cxoinsight/digitizing-pharmaceuticals-nwid-269.html?utm_source=google&utm_campaign=medicaltechoutlook_topslider